Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius Medical Care : North America invests in innovative medical wearable venture

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/09/2019 | 01:33pm EDT

Fresenius Medical Care North America (FMCNA) has announced an investment in BioIntelliSense, a Denver-based company that is developing a medical grade data services platform for continuous remote health monitoring, predictive analytics and algorithmic clinical insights. FMCNA is committed to bringing its expertise in advanced analytics and artificial intelligence to the development and deployment of this system in cooperation with BioIntelliSense. The aim is to jointly create clinical pathways that can alert clinicians to the need for early intervention, potentially preventing patients from complications and, thus, reducing unnecessary as well as costly hospitalizations. The investment, therefore, supports Fresenius Medical Care's strategic goal to improve monitoring, interventions and outcomes for patients living with kidney disease and other chronic illnesses in order to increase their quality of life.

Disclaimer

FMC - Fresenius Medical Care AG & Co. KGaA published this content on 09 July 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 July 2019 17:32:05 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FRESENIUS MEDICAL CARE AG
08/19FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
08/13FRESENIUS6CPRF : SANJOSE will reform the dialysis zone of the Lozano Blesa Hospi..
AQ
08/12FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
08/08FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 40, Section ..
EQ
08/07FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
08/05FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
07/30FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 50 of the Wp..
EQ
07/30Bridgepoint tests appetite for $2.2 billion dialysis clinic firm Diaverum - s..
RE
07/30Fresenius slides as weakness in dialysis unit offsets improved outlook
RE
07/30FRESENIUS MEDICAL CARE : Trades Lower After 2Q Results
DJ
More news
Financials (USD)
Sales 2019 19 412 M
EBIT 2019 2 606 M
Net income 2019 1 304 M
Debt 2019 8 857 M
Yield 2019 1,88%
P/E ratio 2019 15,6x
P/E ratio 2020 13,2x
EV / Sales2019 1,52x
EV / Sales2020 1,40x
Capitalization 20 629 M
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 88,32  $
Last Close Price 67,71  $
Spread / Highest target 64,6%
Spread / Average Target 30,4%
Spread / Lowest Target -27,3%
EPS Revisions
Managers
NameTitle
Rice Powell Chief Executive Officer
Dieter Schenk Chairman-Supervisory Board
Michael Brosnan Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
William P. Johnston Member-Supervisory Board